Chemed Co. (NYSE:CHE) Stock Position Trimmed by MetLife Investment Management LLC

MetLife Investment Management LLC trimmed its position in shares of Chemed Co. (NYSE:CHE) by 2.4% in the third quarter, HoldingsChannel reports. The firm owned 7,845 shares of the company’s stock after selling 193 shares during the period. MetLife Investment Management LLC’s holdings in Chemed were worth $4,715,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of CHE. Townsquare Capital LLC acquired a new position in shares of Chemed during the third quarter worth approximately $4,115,000. BNP Paribas Financial Markets raised its stake in Chemed by 36.2% during the 3rd quarter. BNP Paribas Financial Markets now owns 26,381 shares of the company’s stock valued at $15,854,000 after acquiring an additional 7,007 shares in the last quarter. FMR LLC boosted its position in Chemed by 23.8% during the 3rd quarter. FMR LLC now owns 238,616 shares of the company’s stock worth $143,401,000 after acquiring an additional 45,917 shares during the period. Loomis Sayles & Co. L P grew its stake in shares of Chemed by 0.4% in the third quarter. Loomis Sayles & Co. L P now owns 29,159 shares of the company’s stock worth $17,523,000 after purchasing an additional 108 shares in the last quarter. Finally, Centaurus Financial Inc. increased its holdings in shares of Chemed by 136.2% during the third quarter. Centaurus Financial Inc. now owns 5,071 shares of the company’s stock valued at $3,048,000 after purchasing an additional 2,924 shares during the period. Institutional investors own 95.85% of the company’s stock.

Chemed Stock Up 0.2 %

NYSE:CHE opened at $572.39 on Monday. The business’s 50-day moving average price is $578.27 and its 200 day moving average price is $565.05. Chemed Co. has a 52-week low of $523.33 and a 52-week high of $654.62. The firm has a market cap of $8.61 billion, a P/E ratio of 28.92, a PEG ratio of 2.43 and a beta of 0.46.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The company had revenue of $606.18 million for the quarter, compared to analyst estimates of $612.22 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. Chemed’s revenue was up 7.4% on a year-over-year basis. During the same quarter last year, the company posted $5.32 EPS. Sell-side analysts expect that Chemed Co. will post 21.43 EPS for the current year.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Monday, November 18th will be paid a $0.50 dividend. The ex-dividend date is Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. Chemed’s dividend payout ratio is currently 10.11%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on CHE. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a report on Saturday. Royal Bank of Canada decreased their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a report on Tuesday, November 5th.

Insiders Place Their Bets

In other news, EVP Nicholas Michael Westfall sold 1,713 shares of Chemed stock in a transaction on Monday, September 9th. The stock was sold at an average price of $569.35, for a total transaction of $975,296.55. Following the transaction, the executive vice president now owns 6,109 shares in the company, valued at approximately $3,478,159.15. The trade was a 21.90 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Thursday, September 26th. The stock was sold at an average price of $598.81, for a total value of $1,197,620.00. Following the completion of the sale, the chief executive officer now directly owns 103,735 shares of the company’s stock, valued at approximately $62,117,555.35. This represents a 1.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 6,845 shares of company stock worth $3,978,798. Company insiders own 3.32% of the company’s stock.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.